Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 67448A106 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13G
|
9.7% |
8/10/2026
Event 8/3/2026
|
||
| RA Capital Management, L.P. | 9.7% | |||
| Peter Kolchinsky | 9.7% | |||
| Rajeev Shah | 9.7% | |||
| RA Capital Healthcare Fund, L.P. | 8.0% | |||
|
Paradigm Biocapital Advisors LP
13G
|
6.6% |
10/5/2026
Event 9/28/2026
|
||
| Paradigm BioCapital Advisors LP | 6.6% | |||
| Paradigm BioCapital Advisors GP LLC | 6.6% | |||
| Senai Asefaw, M.D. | 6.6% | |||
| Paradigm BioCapital International Fund Ltd. | 5.9% | |||
|
Deep Track Capital, LP
13G
|
5.4% |
8/11/2026
Event 8/4/2026
|
||
| Deep Track Capital, LP | 5.4% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 5.1% | |||
| David Kroin | 5.4% | |||
| Deep Track Special Opportunities Fund, LP. | 0.3% | |||
| Novo Holdings A/S 13G | 5.1% |
8/10/2026
Event 8/3/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Atlas Venture Fund X, L.P.
13G
|
4.3% |
8/10/2026
Event 8/3/2026
|
||
| Atlas Venture Fund X, L.P. | 4.3% | |||
| Atlas Venture Associates X, L.P. | 4.3% | |||
| Atlas Venture Associates X, LLC | 4.3% | |||
| Atlas Venture Opportunity Fund I, L.P. | 1.7% | |||
| Atlas Venture Associates Opportunity I, L.P. | 1.7% | |||
| Atlas Venture Associates Opportunity I, LLC | 1.7% | |||
| Atlas Venture Opportunity Fund II, L.P. | 0.9% | |||
| Atlas Venture Associates Opportunity II, L.P. | 0.9% | |||
| Atlas Venture Associates Opportunity II, LLC | 0.9% | |||
| Atlas Venture Opportunity Fund III, L.P. | 0.3% | |||
| Atlas Venture Associates Opportunity III, L.P. | 0.3% | |||
| Atlas Venture Associates Opportunity III, LLC | 0.3% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|